{
    "eid": "2-s2.0-85019605601",
    "title": "Thailand national guidelines for the prevention of mother-to-child transmission of HIV 2016",
    "cover-date": "2017-04-01",
    "subject-areas": [
        {
            "$": "General Biochemistry",
            "@code": "1300"
        },
        {
            "$": "General Medicine",
            "@code": "2700"
        }
    ],
    "keywords": [
        "Guidelines",
        "HIV",
        "Mother-to-child transmission",
        "Thailand"
    ],
    "authors": [
        "Rangsima Lolekha"
    ],
    "citedby-count": 12,
    "ref-count": 44,
    "ref-list": [
        "Elimination of mother-to-child transmission of HIV - Thailand",
        "Reduction in mother-to-child transmission of HIV in Thailand, 2001-2003: Results from population-based surveillance in six provinces",
        "Thai national guidelines for the prevention of motherto-child transmission of HIV: March 2010",
        "National Guidelines on HIV/AIDS Diagnosis and Treatment: Thailand 2014",
        "2014 Thailand AIDS Response Progress Report (Reporting Period:2012-2013)",
        "9th IAS Conference on HIV Science 2017",
        "Guidance on Couples HIV Testing and Counselling Including Antiretroviral Therapy for Treatment and Prevention in Serodiscordant Couples: Recommendations for a Public Health Approach",
        "Assessment of a couples HIV counseling and testing program for pregnant women and their partners in antenatal care (ANC) in 7 provinces, Thailand",
        "Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand",
        "Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach - Second Edition",
        "Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendation for a Public Health Approach",
        "Panel on Treatment of HIV-infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States",
        "A case series of third-trimester raltegravir initiation: Impact on maternal HIV-1 viral load and obstetrical outcomes",
        "Use of raltegravir in a late presenter HIV-1 woman in advanced gestational age: Case report and literature review",
        "Public Health Nutr.",
        "Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial",
        "Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network for Prevention Trials 012",
        "Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: Association with timing of maternal intrapartum nevirapine dose",
        "Programmatic Update: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants EXECUTIVE SUMMARY",
        "Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: A randomized clinical trial",
        "Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women",
        "Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011",
        "Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand",
        "Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models.",
        "Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus",
        "Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084",
        "Pneumocystis carinii pneumonia in pregnancy",
        "Panel on Opportunistic Infections in HIV-infected Adults and Adolescents. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America",
        "Antifungal drugs during pregnancy: An updated review",
        "Duration of ruptured membranes and vertical transmission of HIV-1: A meta-analysis from 15 prospective cohort studies",
        "Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1",
        "Human immunodeffciency virus and pregnancy",
        "Panel on Treatment of HIV-infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States",
        "Acute human immunodeficiency virus infection",
        "Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of hiv infection in heterosexually active adults",
        "Achieving safe conception in HIV-discordant couples: The potential role of oral preexposure prophylaxis (PrEP) in the United States",
        "Evaluating a new strategy for prophylaxis to prevent Pneumocystis carinii pneumonia in HIV-exposed infants in Thailand",
        "Pharmacokinetics and tolerance of zidovudine in preterm infants",
        "Medical Eligibility Criteria for Contraceptive Use",
        "The levonorgestrel-releasing intrauterine system in human immunodeficiency virusinfected women: Z 5-year follow-up study",
        "Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz",
        "Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093",
        "Drug interactions between antiretrovirals and hormonal contraceptives"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nontaburi",
            "affilname": "Thailand Ministry of Public Health",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Ramathibodi Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Siriraj Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Thai Red Cross Agency",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "affilname": "Khon Kaen University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}